Literature DB >> 16097137

Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.

Harvey J Clewell1, P Robinan Gentry, Janet E Kester, Melvin E Andersen.   

Abstract

One of the more problematic aspects of the application of physiologically based pharmacokinetic (PBPK) models in risk assessment is the question of whether the model has been adequately validated to provide confidence in the dose metrics calculated with it. A number of PBPK models have been developed for perchloroethylene (PCE), differing primarily in the parameters estimated for metabolism. All of the models provide reasonably accurate simulations of selected kinetic data for PCE in mice and humans and could thus be considered to be "validated" to some extent. However, quantitative estimates of PCE cancer risk are critically dependent on the prediction of the rate of metabolism at low environmental exposures. Recent data on the urinary excretion of trichloroacetic acid (TCA), the major metabolite of PCE, for human subjects exposed to lower concentrations than those used in previous studies, make it possible to compare the high- to low-dose extrapolation capability of the various published human models. The model of Gearhart et al., which is the only model to include a description of TCA kinetics, provided the closest predictions of the urinary excretion observed in these low-concentration exposures. Other models overestimated metabolite excretion in this study by 5- to 15-fold. A systematic discrepancy between model predictions and experimental data for the time course of the urinary excretion of TCA suggested a contribution from TCA formed by metabolism of PCE in the kidney and excreted directly into the urine. A modification of the model of Gearhart et al. to include metabolism of PCE to TCA in the kidney at 10% of the capacity of the liver, with direct excretion of the TCA formed in the kidney into the urine, markedly improved agreement with the experimental time-course data, without altering predictions of liver metabolism. This case study with PCE demonstrates the danger of relying on parent chemical kinetic data to validate a model that will be used for the prediction of metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097137     DOI: 10.1080/10408440590931994

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  7 in total

1.  Toxicity testing in the 21st century: a vision and a strategy.

Authors:  Daniel Krewski; Daniel Acosta; Melvin Andersen; Henry Anderson; John C Bailar; Kim Boekelheide; Robert Brent; Gail Charnley; Vivian G Cheung; Sidney Green; Karl T Kelsey; Nancy I Kerkvliet; Abby A Li; Lawrence McCray; Otto Meyer; Reid D Patterson; William Pennie; Robert A Scala; Gina M Solomon; Martin Stephens; James Yager; Lauren Zeise
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-02       Impact factor: 6.393

2.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

3.  Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).

Authors:  M Moiz Mumtaz; Meredith Ray; Susan R Crowell; Deborah Keys; Jeffrey Fisher; Patricia Ruiz
Journal:  J Toxicol Environ Health A       Date:  2012

4.  An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants.

Authors:  Mathieu Valcke; Kannan Krishnan
Journal:  Int J Environ Res Public Health       Date:  2010-11-17       Impact factor: 3.390

Review 5.  Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants.

Authors:  Patricia Ruiz; Meredith Ray; Jeffrey Fisher; Moiz Mumtaz
Journal:  Int J Mol Sci       Date:  2011-10-31       Impact factor: 5.923

6.  Application of physiologically based pharmacokinetic models in chemical risk assessment.

Authors:  Moiz Mumtaz; Jeffrey Fisher; Benjamin Blount; Patricia Ruiz
Journal:  J Toxicol       Date:  2012-03-19

7.  Human health effects of tetrachloroethylene: key findings and scientific issues.

Authors:  Kathryn Z Guyton; Karen A Hogan; Cheryl Siegel Scott; Glinda S Cooper; Ambuja S Bale; Leonid Kopylev; Stanley Barone; Susan L Makris; Barbara Glenn; Ravi P Subramaniam; Maureen R Gwinn; Rebecca C Dzubow; Weihsueh A Chiu
Journal:  Environ Health Perspect       Date:  2014-02-14       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.